Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04126200 |
| Title | Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 5) |
| Acronym | DREAMM5 |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | SWE | POL | NOR | NLD | GRC | FRA | ESP | DEU | CAN | BRA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Atlanta | Georgia | 30322 | United States | Details | |
| GSK Investigational Site | Indianapolis | Indiana | 46202 | United States | Details | |
| GSK Investigational Site | Boston | Massachusetts | 02215 | United States | Details | |
| GSK Investigational Site | Grand Rapids | Michigan | 49546 | United States | Details | |
| GSK Investigational Site | Madison | Wisconsin | 53792 | United States | Details | |
| GSK Investigational Site | Fitzroy | Victoria | 3065 | Australia | Details | |
| GSK Investigational Site | Melbourne | Victoria | 3000 | Australia | Details | |
| GSK Investigational Site | Porto Alegre | 90110-270 | Brazil | Details | ||
| GSK Investigational Site | Salvador | 41253-190 | Brazil | Details | ||
| GSK Investigational Site | SAo Paulo | 04537-080 | Brazil | Details | ||
| GSK Investigational Site | Vancouver | British Columbia | V5Z1M9 | Canada | Details | |
| GSK Investigational Site | Halifax | Nova Scotia | B3H 1V7 | Canada | Details | |
| GSK Investigational Site | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| GSK Investigational Site | Lille | 59037 | France | Details | ||
| GSK Investigational Site | Villejuif Cedex | 94805 | France | Details | ||
| GSK Investigational Site | Frankfurt | 60590 | Germany | Details | ||
| GSK Investigational Site | Hamburg | 20246 | Germany | Details | ||
| GSK Investigational Site | Kiel | 24105 | Germany | Details | ||
| GSK Investigational Site | Leipzig | 04103 | Germany | Details | ||
| GSK Investigational Site | Athens | 11528 | Greece | Details | ||
| GSK Investigational Site | Incheon | 21565 | Korea, Republic of | Details | ||
| GSK Investigational Site | Seoul | 03080 | Korea, Republic of | Details | ||
| GSK Investigational Site | Seoul | 06351 | Korea, Republic of | Details | ||
| GSK Investigational Site | Seoul | 06591 | Korea, Republic of | Details | ||
| GSK Investigational Site | Ulsan | 44033 | Korea, Republic of | Details | ||
| GSK Investigational Site | Ciudad de Mexico | 01330 | Mexico | Details | ||
| GSK Investigational Site | Leeuwarden | 8934 AD | Netherlands | Details | ||
| GSK Investigational Site | Utrecht | 3584 CX | Netherlands | Details | ||
| GSK Investigational Site | Oslo | 0450 | Norway | Details | ||
| GSK Investigational Site | Katowice | 40-519 | Poland | Details | ||
| GSK Investigational Site | Lublin | 20-081 | Poland | Details | ||
| GSK Investigational Site | Moscow | 125284 | Russian Federation | Details | ||
| GSK Investigational Site | Badalona | 08916 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28027 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28040 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28041 | Spain | Details | ||
| GSK Investigational Site | PamplonaNavarra | 31008 | Spain | Details | ||
| GSK Investigational Site | Pozuelo De AlarcOn Madr | 28223 | Spain | Details | ||
| GSK Investigational Site | Falun | SE-791 82 | Sweden | Details | ||
| GSK Investigational Site | Stockholm | SE-141 86 | Sweden | Details |